Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Experimental Neuroendocrinology, PL 31343 Krakow, Poland.
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, PL 30239 Krakow, Poland.
Biomolecules. 2024 May 9;14(5):564. doi: 10.3390/biom14050564.
Cannabidiol (CBD) appears to possess some neuroprotective properties, but experimental data are still inconsistent. Therefore, this in vitro study aimed to compare the effects of CBD in a wide range of concentrations on oxidative stress and excitotoxic-related cell damage. Results showed that low concentrations of CBD ameliorated the HO-evoked cell damage of primary cortical neuronal cell culture. However, higher concentrations of CBD alone (5-25 μM) decreased the viability of cortical neurons in a concentration-dependent manner and aggravated the toxic effects of hydrogen peroxide (HO). Neuroprotection mediated by CBD in primary neurons against HO was not associated with a direct influence on ROS production nor inhibition of caspase-3, but we found protective effects of CBD at the level of mitochondrial membrane potential and DNA fragmentation. However, CBD had no protective effect on the glutamate-induced cell damage of cortical neurons, and in higher concentrations, it enhanced the toxic effects of this cell-damaging factor. Likewise, CBD, depending on its concentration, at least did not affect or even enhance cortical cellular damage exposed to oxygen-glucose deprivation (OGD). Finally, we showed that CBD in submicromolar or low micromolar concentrations significantly protected human neuronal-like SH-SY5Y cells against HO- and 6-hydroxydopamine (6-OHDA)-induced cell damage. Our data indicate that CBD has a dual effect on oxidative stress-induced neuronal death-in low concentrations, it is neuroprotective, but in higher ones, it may display neurotoxic activity. On the other hand, in excitotoxic-related models, CBD was ineffective or enhanced cell damage. Our data support the notion that the neuroprotective effects of CBD strongly depend on its concentration and experimental model of neuronal death.
大麻二酚(CBD)似乎具有一些神经保护特性,但实验数据仍然不一致。因此,这项体外研究旨在比较 CBD 在广泛浓度范围内对氧化应激和兴奋性毒性相关细胞损伤的影响。结果表明,低浓度的 CBD 改善了原代皮质神经元细胞培养物中 HO 引起的细胞损伤。然而,较高浓度的 CBD(5-25 μM)会以浓度依赖的方式降低皮质神经元的活力,并加重过氧化氢(HO)的毒性作用。CBD 在原代神经元中对 HO 介导的神经保护作用与直接影响 ROS 产生或抑制半胱天冬酶-3无关,但我们发现 CBD 在线粒体膜电位和 DNA 片段化水平上具有保护作用。然而,CBD 对皮质神经元谷氨酸诱导的细胞损伤没有保护作用,而且在较高浓度下,它会增强这种细胞损伤因子的毒性作用。同样,CBD 至少不会影响皮质细胞暴露于氧葡萄糖剥夺(OGD)时的细胞损伤,或者甚至增强这种损伤,这取决于其浓度。最后,我们表明,亚毫摩尔或低毫摩尔浓度的 CBD 可显著保护人神经样 SH-SY5Y 细胞免受 HO 和 6-羟基多巴胺(6-OHDA)诱导的细胞损伤。我们的数据表明,CBD 对氧化应激诱导的神经元死亡具有双重作用——在低浓度下,它具有神经保护作用,但在较高浓度下,它可能显示出神经毒性活性。另一方面,在兴奋性毒性相关模型中,CBD 无效或加重了细胞损伤。我们的数据支持这样一种观点,即 CBD 的神经保护作用强烈依赖于其浓度和神经元死亡的实验模型。